Global Short-Acting Nicotine Replacement Therapy Products Supply, Demand and Key Producers, 2026-2032

November 2026 | 147 pages | ID: G4117A8C350EEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Short-Acting Nicotine Replacement Therapy Products market size is expected to reach $ 2676 million by 2032, rising at a market growth of 5.5% CAGR during the forecast period (2026-2032).

Short-acting nicotine replacement therapy (NRT) products are non-combustible smoking cessation aids designed to rapidly release and deliver nicotine—typically via the oral mucosa or nasal passages—to alleviate sudden cravings and nicotine withdrawal symptoms during the quitting process. Key examples include nicotine gum, lozenges, oral sprays, nasal sprays, and certain fast-release oral formulations. Sold primarily through pharmacies, hospitals, retail outlets, and online platforms, these products are widely used to help smokers quit and reduce tobacco dependence; their market continues to grow alongside the advancement of public health tobacco control policies, rising awareness regarding smoking cessation, and increasing consumer acceptance of over-the-counter smoking cessation aids.

The short-acting nicotine replacement therapy products market is primarily driven by continued implementation of tobacco-control policies, rising motivation among smokers to quit, growing demand for nicotine dependence treatment, and increasing consumer acceptance of convenient smoking cessation aids. Compared with long-acting products such as nicotine patches, short-acting formats including nicotine gum, lozenges, oral sprays, and nasal sprays can provide relatively rapid relief from sudden cravings and withdrawal symptoms, while offering flexible, on-demand dosing. These characteristics make them suitable both as standalone therapies and in combination with long-acting nicotine patches for more comprehensive craving management. At the same time, wider promotion of evidence-based smoking cessation interventions by healthcare providers and public health organizations, expansion of over-the-counter and online pharmacy channels, and growing awareness of the health risks associated with smoking and secondhand smoke are expanding the potential user base. Continued innovation in flavors, dosage forms, nicotine strengths, and portability is also improving treatment adherence and user convenience, further supporting growth of the global short-acting nicotine replacement therapy products market.

Report Scope

This report studies the global Short-Acting Nicotine Replacement Therapy Products demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Short-Acting Nicotine Replacement Therapy Products, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Short-Acting Nicotine Replacement Therapy Products that contribute to its increasing demand across many markets.

Highlights and key features of the study

  • Global Short-Acting Nicotine Replacement Therapy Products total market, 2021-2032, (USD Million)
  • Global Short-Acting Nicotine Replacement Therapy Products total market by region & country, CAGR, 2021-2032, (USD Million)
  • U.S. VS China: Short-Acting Nicotine Replacement Therapy Products total market, key domestic companies, and share, (USD Million)
  • Global Short-Acting Nicotine Replacement Therapy Products revenue by player, revenue and market share 2021-2026, (USD Million)
  • Global Short-Acting Nicotine Replacement Therapy Products total market by Type, CAGR, 2021-2032, (USD Million)
  • Global Short-Acting Nicotine Replacement Therapy Products total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Short-Acting Nicotine Replacement Therapy Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kenvue, Perrigo, Dr. Reddy's Laboratories, Haleon, Philip Morris International, Cipla, Rusan Pharma, Glenmark Pharmaceuticals, Piramal Pharma, Rubicon Consumer Healthcare, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Short-Acting Nicotine Replacement Therapy Products market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Short-Acting Nicotine Replacement Therapy Products Market, By Region:

  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World

Market Segmentation

Global Short-Acting Nicotine Replacement Therapy Products Market, Segmentation by Type:

  • Nicotine Gum
  • Nicotine Lozenges
  • Nicotine Mouth Spray
  • Nicotine Nasal Spray
  • Others

Global Short-Acting Nicotine Replacement Therapy Products Market, Segmentation by Dose:

  • Low Dose
  • Medium Dose
  • High Dose

Global Short-Acting Nicotine Replacement Therapy Products Market, Segmentation by Application:

  • Online Sales
  • Offline Sales

Companies Profiled:

  • Kenvue
  • Perrigo
  • Dr. Reddy's Laboratories
  • Haleon
  • Philip Morris International
  • Cipla
  • Rusan Pharma
  • Glenmark Pharmaceuticals
  • Piramal Pharma
  • Rubicon Consumer Healthcare
  • Alkalon
  • Sparsha Pharma
  • TFI India Labs
  • Nico Orgo Marketing
  • Lucy Goods
  • Blip
  • AdhexPharma
  • Jones

Key Questions Answered

1. How big is the global Short-Acting Nicotine Replacement Therapy Products market?
2. What is the demand of the global Short-Acting Nicotine Replacement Therapy Products market?
3. What is the year over year growth of the global Short-Acting Nicotine Replacement Therapy Products market?
4. What is the total value of the global Short-Acting Nicotine Replacement Therapy Products market?
5. Who are the Major Players in the global Short-Acting Nicotine Replacement Therapy Products market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Short-Acting Nicotine Replacement Therapy Products Introduction
1.2 World Short-Acting Nicotine Replacement Therapy Products Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Short-Acting Nicotine Replacement Therapy Products Total Market by Region (by Headquarter Location)
  1.3.1 World Short-Acting Nicotine Replacement Therapy Products Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032)
  1.3.3 China Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032)
  1.3.4 Europe Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032)
  1.3.5 Japan Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032)
  1.3.6 South Korea Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032)
  1.3.7 ASEAN Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032)
  1.3.8 India Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Short-Acting Nicotine Replacement Therapy Products Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032)
2.2 World Short-Acting Nicotine Replacement Therapy Products Consumption Value by Region
  2.2.1 World Short-Acting Nicotine Replacement Therapy Products Consumption Value by Region (2021-2026)
  2.2.2 World Short-Acting Nicotine Replacement Therapy Products Consumption Value Forecast by Region (2027-2032)
2.3 United States Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032)
2.4 China Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032)
2.5 Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032)
2.6 Japan Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032)
2.7 South Korea Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032)
2.8 ASEAN Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032)
2.9 India Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032)

3 WORLD SHORT-ACTING NICOTINE REPLACEMENT THERAPY PRODUCTS COMPANIES COMPETITIVE ANALYSIS

3.1 World Short-Acting Nicotine Replacement Therapy Products Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Short-Acting Nicotine Replacement Therapy Products Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Short-Acting Nicotine Replacement Therapy Products in 2025
  3.2.3 Global Concentration Ratios (CR8) for Short-Acting Nicotine Replacement Therapy Products in 2025
3.3 Short-Acting Nicotine Replacement Therapy Products Company Evaluation Quadrant
3.4 Short-Acting Nicotine Replacement Therapy Products Market: Overall Company Footprint Analysis
  3.4.1 Short-Acting Nicotine Replacement Therapy Products Market: Region Footprint
  3.4.2 Short-Acting Nicotine Replacement Therapy Products Market: Company Product Type Footprint
  3.4.3 Short-Acting Nicotine Replacement Therapy Products Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Short-Acting Nicotine Replacement Therapy Products Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Short-Acting Nicotine Replacement Therapy Products Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: Short-Acting Nicotine Replacement Therapy Products Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Short-Acting Nicotine Replacement Therapy Products Consumption Value Comparison
  4.2.1 United States VS China: Short-Acting Nicotine Replacement Therapy Products Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Short-Acting Nicotine Replacement Therapy Products Companies and Market Share, 2021-2026
  4.3.1 United States Based Short-Acting Nicotine Replacement Therapy Products Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue, (2021-2026)
4.4 China Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue and Market Share, 2021-2026
  4.4.1 China Based Short-Acting Nicotine Replacement Therapy Products Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue, (2021-2026)
4.5 Rest of World Based Short-Acting Nicotine Replacement Therapy Products Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based Short-Acting Nicotine Replacement Therapy Products Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Short-Acting Nicotine Replacement Therapy Products Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Nicotine Gum
  5.2.2 Nicotine Lozenges
  5.2.3 Nicotine Mouth Spray
  5.2.4 Nicotine Nasal Spray
  5.2.5 Others
5.3 Market Segment by Type
  5.3.1 World Short-Acting Nicotine Replacement Therapy Products Market Size by Type (2021-2026)
  5.3.2 World Short-Acting Nicotine Replacement Therapy Products Market Size by Type (2027-2032)
  5.3.3 World Short-Acting Nicotine Replacement Therapy Products Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY DOSE

6.1 World Short-Acting Nicotine Replacement Therapy Products Market Size Overview by Dose: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dose
  6.2.1 Low Dose
  6.2.2 Medium Dose
  6.2.3 High Dose
6.3 Market Segment by Dose
  6.3.1 World Short-Acting Nicotine Replacement Therapy Products Market Size by Dose (2021-2026)
  6.3.2 World Short-Acting Nicotine Replacement Therapy Products Market Size by Dose (2027-2032)
  6.3.3 World Short-Acting Nicotine Replacement Therapy Products Market Size Market Share by Dose (2027-2032)

7 MARKET ANALYSIS BY APPLICATION

7.1 World Short-Acting Nicotine Replacement Therapy Products Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
  7.2.1 Online Sales
  7.2.2 Offline Sales
7.3 Market Segment by Application
  7.3.1 World Short-Acting Nicotine Replacement Therapy Products Market Size by Application (2021-2026)
  7.3.2 World Short-Acting Nicotine Replacement Therapy Products Market Size by Application (2027-2032)
  7.3.3 World Short-Acting Nicotine Replacement Therapy Products Market Size Market Share by Application (2021-2032)

8 COMPANY PROFILES

8.1 Kenvue
  8.1.1 Kenvue Details
  8.1.2 Kenvue Major Business
  8.1.3 Kenvue Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.1.4 Kenvue Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.1.5 Kenvue Recent Developments/Updates
  8.1.6 Kenvue Competitive Strengths & Weaknesses
8.2 Perrigo
  8.2.1 Perrigo Details
  8.2.2 Perrigo Major Business
  8.2.3 Perrigo Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.2.4 Perrigo Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.2.5 Perrigo Recent Developments/Updates
  8.2.6 Perrigo Competitive Strengths & Weaknesses
8.3 Dr. Reddy's Laboratories
  8.3.1 Dr. Reddy's Laboratories Details
  8.3.2 Dr. Reddy's Laboratories Major Business
  8.3.3 Dr. Reddy's Laboratories Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.3.4 Dr. Reddy's Laboratories Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
  8.3.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
8.4 Haleon
  8.4.1 Haleon Details
  8.4.2 Haleon Major Business
  8.4.3 Haleon Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.4.4 Haleon Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.4.5 Haleon Recent Developments/Updates
  8.4.6 Haleon Competitive Strengths & Weaknesses
8.5 Philip Morris International
  8.5.1 Philip Morris International Details
  8.5.2 Philip Morris International Major Business
  8.5.3 Philip Morris International Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.5.4 Philip Morris International Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.5.5 Philip Morris International Recent Developments/Updates
  8.5.6 Philip Morris International Competitive Strengths & Weaknesses
8.6 Cipla
  8.6.1 Cipla Details
  8.6.2 Cipla Major Business
  8.6.3 Cipla Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.6.4 Cipla Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.6.5 Cipla Recent Developments/Updates
  8.6.6 Cipla Competitive Strengths & Weaknesses
8.7 Rusan Pharma
  8.7.1 Rusan Pharma Details
  8.7.2 Rusan Pharma Major Business
  8.7.3 Rusan Pharma Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.7.4 Rusan Pharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.7.5 Rusan Pharma Recent Developments/Updates
  8.7.6 Rusan Pharma Competitive Strengths & Weaknesses
8.8 Glenmark Pharmaceuticals
  8.8.1 Glenmark Pharmaceuticals Details
  8.8.2 Glenmark Pharmaceuticals Major Business
  8.8.3 Glenmark Pharmaceuticals Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.8.4 Glenmark Pharmaceuticals Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.8.5 Glenmark Pharmaceuticals Recent Developments/Updates
  8.8.6 Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
8.9 Piramal Pharma
  8.9.1 Piramal Pharma Details
  8.9.2 Piramal Pharma Major Business
  8.9.3 Piramal Pharma Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.9.4 Piramal Pharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.9.5 Piramal Pharma Recent Developments/Updates
  8.9.6 Piramal Pharma Competitive Strengths & Weaknesses
8.10 Rubicon Consumer Healthcare
  8.10.1 Rubicon Consumer Healthcare Details
  8.10.2 Rubicon Consumer Healthcare Major Business
  8.10.3 Rubicon Consumer Healthcare Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.10.4 Rubicon Consumer Healthcare Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.10.5 Rubicon Consumer Healthcare Recent Developments/Updates
  8.10.6 Rubicon Consumer Healthcare Competitive Strengths & Weaknesses
8.11 Alkalon
  8.11.1 Alkalon Details
  8.11.2 Alkalon Major Business
  8.11.3 Alkalon Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.11.4 Alkalon Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.11.5 Alkalon Recent Developments/Updates
  8.11.6 Alkalon Competitive Strengths & Weaknesses
8.12 Sparsha Pharma
  8.12.1 Sparsha Pharma Details
  8.12.2 Sparsha Pharma Major Business
  8.12.3 Sparsha Pharma Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.12.4 Sparsha Pharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.12.5 Sparsha Pharma Recent Developments/Updates
  8.12.6 Sparsha Pharma Competitive Strengths & Weaknesses
8.13 TFI India Labs
  8.13.1 TFI India Labs Details
  8.13.2 TFI India Labs Major Business
  8.13.3 TFI India Labs Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.13.4 TFI India Labs Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.13.5 TFI India Labs Recent Developments/Updates
  8.13.6 TFI India Labs Competitive Strengths & Weaknesses
8.14 Nico Orgo Marketing
  8.14.1 Nico Orgo Marketing Details
  8.14.2 Nico Orgo Marketing Major Business
  8.14.3 Nico Orgo Marketing Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.14.4 Nico Orgo Marketing Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.14.5 Nico Orgo Marketing Recent Developments/Updates
  8.14.6 Nico Orgo Marketing Competitive Strengths & Weaknesses
8.15 Lucy Goods
  8.15.1 Lucy Goods Details
  8.15.2 Lucy Goods Major Business
  8.15.3 Lucy Goods Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.15.4 Lucy Goods Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.15.5 Lucy Goods Recent Developments/Updates
  8.15.6 Lucy Goods Competitive Strengths & Weaknesses
8.16 Blip
  8.16.1 Blip Details
  8.16.2 Blip Major Business
  8.16.3 Blip Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.16.4 Blip Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.16.5 Blip Recent Developments/Updates
  8.16.6 Blip Competitive Strengths & Weaknesses
8.17 AdhexPharma
  8.17.1 AdhexPharma Details
  8.17.2 AdhexPharma Major Business
  8.17.3 AdhexPharma Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.17.4 AdhexPharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.17.5 AdhexPharma Recent Developments/Updates
  8.17.6 AdhexPharma Competitive Strengths & Weaknesses
8.18 Jones
  8.18.1 Jones Details
  8.18.2 Jones Major Business
  8.18.3 Jones Short-Acting Nicotine Replacement Therapy Products Product and Services
  8.18.4 Jones Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  8.18.5 Jones Recent Developments/Updates
  8.18.6 Jones Competitive Strengths & Weaknesses

9 INDUSTRY CHAIN ANALYSIS

9.1 Short-Acting Nicotine Replacement Therapy Products Industry Chain
9.2 Short-Acting Nicotine Replacement Therapy Products Upstream Analysis
9.3 Short-Acting Nicotine Replacement Therapy Products Midstream Analysis
9.4 Short-Acting Nicotine Replacement Therapy Products Downstream Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES

Table 1. World Short-Acting Nicotine Replacement Therapy Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Short-Acting Nicotine Replacement Therapy Products Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Short-Acting Nicotine Replacement Therapy Products Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Short-Acting Nicotine Replacement Therapy Products Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Short-Acting Nicotine Replacement Therapy Products Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Short-Acting Nicotine Replacement Therapy Products Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Short-Acting Nicotine Replacement Therapy Products Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Short-Acting Nicotine Replacement Therapy Products Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Short-Acting Nicotine Replacement Therapy Products Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Short-Acting Nicotine Replacement Therapy Products Players in 2025
Table 12. World Short-Acting Nicotine Replacement Therapy Products Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Short-Acting Nicotine Replacement Therapy Products Company Evaluation Quadrant
Table 14. Head Office of Key Short-Acting Nicotine Replacement Therapy Products Players
Table 15. Short-Acting Nicotine Replacement Therapy Products Market: Company Product Type Footprint
Table 16. Short-Acting Nicotine Replacement Therapy Products Market: Company Product Application Footprint
Table 17. Short-Acting Nicotine Replacement Therapy Products Mergers & Acquisitions Activity
Table 18. United States VS China Short-Acting Nicotine Replacement Therapy Products Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Short-Acting Nicotine Replacement Therapy Products Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Short-Acting Nicotine Replacement Therapy Products Companies, Headquarters (States, Country)
Table 21. United States Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue Market Share (2021-2026)
Table 23. China Based Short-Acting Nicotine Replacement Therapy Products Companies, Headquarters (Province, Country)
Table 24. China Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue Market Share (2021-2026)
Table 26. Rest of World Based Short-Acting Nicotine Replacement Therapy Products Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Short-Acting Nicotine Replacement Therapy Products Revenue Market Share (2021-2026)
Table 29. World Short-Acting Nicotine Replacement Therapy Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Short-Acting Nicotine Replacement Therapy Products Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Short-Acting Nicotine Replacement Therapy Products Market Size by Type (2027-2032) & (USD Million)
Table 32. World Short-Acting Nicotine Replacement Therapy Products Market Size by Dose, (USD Million), 2021 & 2025 & 2032
Table 33. World Short-Acting Nicotine Replacement Therapy Products Market Size Value by Dose (2021-2026) & (USD Million)
Table 34. World Short-Acting Nicotine Replacement Therapy Products Market Size by Dose (2027-2032) & (USD Million)
Table 35. World Short-Acting Nicotine Replacement Therapy Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Short-Acting Nicotine Replacement Therapy Products Market Size by Application (2021-2026) & (USD Million)
Table 37. World Short-Acting Nicotine Replacement Therapy Products Market Size by Application (2027-2032) & (USD Million)
Table 38. Kenvue Basic Information, Manufacturing Base and Competitors
Table 39. Kenvue Major Business
Table 40. Kenvue Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 41. Kenvue Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Kenvue Recent Developments/Updates
Table 43. Kenvue Competitive Strengths & Weaknesses
Table 44. Perrigo Basic Information, Manufacturing Base and Competitors
Table 45. Perrigo Major Business
Table 46. Perrigo Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 47. Perrigo Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Perrigo Recent Developments/Updates
Table 49. Perrigo Competitive Strengths & Weaknesses
Table 50. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 51. Dr. Reddy's Laboratories Major Business
Table 52. Dr. Reddy's Laboratories Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 53. Dr. Reddy's Laboratories Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Dr. Reddy's Laboratories Recent Developments/Updates
Table 55. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
Table 56. Haleon Basic Information, Manufacturing Base and Competitors
Table 57. Haleon Major Business
Table 58. Haleon Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 59. Haleon Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Haleon Recent Developments/Updates
Table 61. Haleon Competitive Strengths & Weaknesses
Table 62. Philip Morris International Basic Information, Manufacturing Base and Competitors
Table 63. Philip Morris International Major Business
Table 64. Philip Morris International Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 65. Philip Morris International Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Philip Morris International Recent Developments/Updates
Table 67. Philip Morris International Competitive Strengths & Weaknesses
Table 68. Cipla Basic Information, Manufacturing Base and Competitors
Table 69. Cipla Major Business
Table 70. Cipla Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 71. Cipla Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Cipla Recent Developments/Updates
Table 73. Cipla Competitive Strengths & Weaknesses
Table 74. Rusan Pharma Basic Information, Manufacturing Base and Competitors
Table 75. Rusan Pharma Major Business
Table 76. Rusan Pharma Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 77. Rusan Pharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Rusan Pharma Recent Developments/Updates
Table 79. Rusan Pharma Competitive Strengths & Weaknesses
Table 80. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 81. Glenmark Pharmaceuticals Major Business
Table 82. Glenmark Pharmaceuticals Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 83. Glenmark Pharmaceuticals Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Glenmark Pharmaceuticals Recent Developments/Updates
Table 85. Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
Table 86. Piramal Pharma Basic Information, Manufacturing Base and Competitors
Table 87. Piramal Pharma Major Business
Table 88. Piramal Pharma Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 89. Piramal Pharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Piramal Pharma Recent Developments/Updates
Table 91. Piramal Pharma Competitive Strengths & Weaknesses
Table 92. Rubicon Consumer Healthcare Basic Information, Manufacturing Base and Competitors
Table 93. Rubicon Consumer Healthcare Major Business
Table 94. Rubicon Consumer Healthcare Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 95. Rubicon Consumer Healthcare Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Rubicon Consumer Healthcare Recent Developments/Updates
Table 97. Rubicon Consumer Healthcare Competitive Strengths & Weaknesses
Table 98. Alkalon Basic Information, Manufacturing Base and Competitors
Table 99. Alkalon Major Business
Table 100. Alkalon Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 101. Alkalon Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Alkalon Recent Developments/Updates
Table 103. Alkalon Competitive Strengths & Weaknesses
Table 104. Sparsha Pharma Basic Information, Manufacturing Base and Competitors
Table 105. Sparsha Pharma Major Business
Table 106. Sparsha Pharma Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 107. Sparsha Pharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Sparsha Pharma Recent Developments/Updates
Table 109. Sparsha Pharma Competitive Strengths & Weaknesses
Table 110. TFI India Labs Basic Information, Manufacturing Base and Competitors
Table 111. TFI India Labs Major Business
Table 112. TFI India Labs Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 113. TFI India Labs Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. TFI India Labs Recent Developments/Updates
Table 115. TFI India Labs Competitive Strengths & Weaknesses
Table 116. Nico Orgo Marketing Basic Information, Manufacturing Base and Competitors
Table 117. Nico Orgo Marketing Major Business
Table 118. Nico Orgo Marketing Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 119. Nico Orgo Marketing Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Nico Orgo Marketing Recent Developments/Updates
Table 121. Nico Orgo Marketing Competitive Strengths & Weaknesses
Table 122. Lucy Goods Basic Information, Manufacturing Base and Competitors
Table 123. Lucy Goods Major Business
Table 124. Lucy Goods Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 125. Lucy Goods Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Lucy Goods Recent Developments/Updates
Table 127. Lucy Goods Competitive Strengths & Weaknesses
Table 128. Blip Basic Information, Manufacturing Base and Competitors
Table 129. Blip Major Business
Table 130. Blip Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 131. Blip Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Blip Recent Developments/Updates
Table 133. Blip Competitive Strengths & Weaknesses
Table 134. AdhexPharma Basic Information, Manufacturing Base and Competitors
Table 135. AdhexPharma Major Business
Table 136. AdhexPharma Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 137. AdhexPharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. AdhexPharma Recent Developments/Updates
Table 139. AdhexPharma Competitive Strengths & Weaknesses
Table 140. Jones Basic Information, Manufacturing Base and Competitors
Table 141. Jones Major Business
Table 142. Jones Short-Acting Nicotine Replacement Therapy Products Product and Services
Table 143. Jones Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Jones Recent Developments/Updates
Table 145. Jones Competitive Strengths & Weaknesses
Table 146. Global Key Players of Short-Acting Nicotine Replacement Therapy Products Upstream (Raw Materials)
Table 147. Global Short-Acting Nicotine Replacement Therapy Products Typical Customers

LIST OF FIGURES

Figure 1. Short-Acting Nicotine Replacement Therapy Products Picture
Figure 2. World Short-Acting Nicotine Replacement Therapy Products Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Short-Acting Nicotine Replacement Therapy Products Total Revenue (2021-2032) & (USD Million)
Figure 4. World Short-Acting Nicotine Replacement Therapy Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Short-Acting Nicotine Replacement Therapy Products Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Short-Acting Nicotine Replacement Therapy Products Revenue (2021-2032) & (USD Million)
Figure 13. Short-Acting Nicotine Replacement Therapy Products Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 16. World Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 18. China Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 23. India Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Short-Acting Nicotine Replacement Therapy Products by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Short-Acting Nicotine Replacement Therapy Products Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Short-Acting Nicotine Replacement Therapy Products Markets in 2025
Figure 27. United States VS China: Short-Acting Nicotine Replacement Therapy Products Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Short-Acting Nicotine Replacement Therapy Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Short-Acting Nicotine Replacement Therapy Products Market Size Market Share by Type in 2025
Figure 31. Nicotine Gum
Figure 32. Nicotine Lozenges
Figure 33. Nicotine Mouth Spray
Figure 34. Nicotine Nasal Spray
Figure 35. Others
Figure 36. World Short-Acting Nicotine Replacement Therapy Products Market Size Market Share by Type (2021-2032)
Figure 37. World Short-Acting Nicotine Replacement Therapy Products Market Size by Dose, (USD Million), 2021 & 2025 & 2032
Figure 38. World Short-Acting Nicotine Replacement Therapy Products Market Size Market Share by Dose in 2025
Figure 39. Low Dose
Figure 40. Medium Dose
Figure 41. High Dose
Figure 42. World Short-Acting Nicotine Replacement Therapy Products Market Size Market Share by Dose (2021-2032)
Figure 43. World Short-Acting Nicotine Replacement Therapy Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 44. World Short-Acting Nicotine Replacement Therapy Products Market Size Market Share by Application in 2025
Figure 45. Online Sales
Figure 46. Offline Sales
Figure 47. World Short-Acting Nicotine Replacement Therapy Products Market Size Market Share by Application (2021-2032)
Figure 48. Short-Acting Nicotine Replacement Therapy Products Industrial Chain
Figure 49. Methodology
Figure 50. Research Process and Data Source